We are live on ! Find out more
CWM

Cranbrook Wealth Management Portfolio holdings

AUM $492M
1-Year Est. Return 14.37%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+14.37%
3 Year Est. Return
+37.85%
5 Year Est. Return
+32.26%
10 Year Est. Return
+118.11%
AUM
$431M
AUM Growth
-$6.95M
Cap. Flow
+$2.43M
Cap. Flow %
0.56%
Top 10 Hldgs %
52.26%
Holding
417
New
41
Increased
81
Reduced
47
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 3.46%
2 Healthcare 2.3%
3 Financials 1.35%
4 Industrials 0.86%
5 Consumer Discretionary 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
376
Crown Holdings
CCK
$12.8B
$662 ﹤0.01%
+8
New +$728
DAN icon
377
Dana Inc
DAN
$2.9B
$636 ﹤0.01%
+55
New +$571
HALO icon
378
Halozyme
HALO
$9.79B
$622 ﹤0.01%
13
VRSN icon
379
VeriSign
VRSN
$26.2B
$621 ﹤0.01%
+3
New +$565
DVA icon
380
DaVita
DVA
$15.4B
$599 ﹤0.01%
+4
New +$627
DB icon
381
Deutsche Bank
DB
$69B
$580 ﹤0.01%
34
LAC
382
Lithium Americas
LAC
$1.01B
$580 ﹤0.01%
195
PARA
383
DELISTED
Paramount Global Class B
PARA
$565 ﹤0.01%
+54
New +$580
LAR
384
Lithium Argentina AG
LAR
$985M
$511 ﹤0.01%
195
SIRI icon
385
SiriusXM
SIRI
$9.98B
$479 ﹤0.01%
+21
New +$536
WBA
386
DELISTED
Walgreens Boots Alliance
WBA
$458 ﹤0.01%
49
VRT icon
387
Vertiv
VRT
$93B
$455 ﹤0.01%
4
SLVM icon
388
Sylvamo
SLVM
$1.49B
$396 ﹤0.01%
5
TER icon
389
Teradyne
TER
$57.6B
$378 ﹤0.01%
3
BPT
390
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$368 ﹤0.01%
676
HI
391
DELISTED
Hillenbrand
HI
$339 ﹤0.01%
11
HAIN icon
392
Hain Celestial
HAIN
$45M
$320 ﹤0.01%
52
SCHG icon
393
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$307 ﹤0.01%
+11
New +$301
KVUE icon
394
Kenvue
KVUE
$36.9B
$257 ﹤0.01%
12
RXRX icon
395
Recursion Pharmaceuticals
RXRX
$1.59B
$237 ﹤0.01%
35
MREO
396
Mereo BioPharma
MREO
$54.7M
$210 ﹤0.01%
60
DBC icon
397
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$193 ﹤0.01%
+9
New +$201
BLNK icon
398
Blink Charging
BLNK
$74.3M
$183 ﹤0.01%
131
CRON
399
Cronos Group
CRON
$1.06B
$158 ﹤0.01%
78
BCLI
400
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$150 ﹤0.01%
+66
New +$122

Similar funds

Cranbrook Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Cranbrook Wealth Management held 417 positions worth $431M, down 1.6% from $438M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Cranbrook Wealth Management's Q4 2024 filing shows 41 new, 81 increased, 47 reduced and 5 closed positions. Its largest new stake was Lockheed Martin: 200 shares worth $97.2K. The largest sale was iShares Core S&P 500 ETF, an estimated $399K.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.

  • Cranbrook Wealth Management's largest Q4 2024 buy was Lockheed Martin: 200 shares worth $97.2K.
  • Cranbrook Wealth Management added most to Vanguard Intermediate-Term Bond ETF in Q4 2024, an estimated $2.26M increase.
  • Cranbrook Wealth Management's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $399K.
  • Cranbrook Wealth Management fully exited Axcelis in Q4 2024, selling an estimated $280K.
  • Cranbrook Wealth Management's ten largest holdings make up 52% of its $431M portfolio in Q4 2024.
  • Cranbrook Wealth Management opened 41 new positions and closed 5 in Q4 2024.
  • Cranbrook Wealth Management's portfolio value fell 1.6% quarter-over-quarter to $431M.

Based on Cranbrook Wealth Management's 13F filing for Q4 2024, filed 15 Jan 2025.